PE/VC investors

Private Equity (PE) and Venture Capital (VC) investors are the catalysts of innovation and growth in the business world. PE firms primarily target established companies, seeking to optimize operations and unlock value through strategic investments and management expertise. They focus on long-term growth and profitability, often preparing businesses for a future sale or IPO. VC investors, by contrast, are the adventurers of finance, injecting capital into high-potential startups and early-stage companies. They embrace risk for the possibility of outsized returns, often becoming invaluable advisors. Both investor types not only bring capital but also strategic guidance, industry connections, and market insights, propelling their portfolio companies towards success.

Investors (6,251)
Investor
Description
More information
Longevity Vision Fund Longevity Vision Fund
Longevity Vision Fund (LVF) is a venture capital fund that invests in technologies with the potential to disrupt life sciences and healthcare to help people live longer and healthier lives. The fund’s mission is to accelerate longevity breakthroughs and to make them more accessible and affordable to everyone LVF provides venture funding (Series A-C / crossover) to health tech, longevity and biotech companies across the following sectors: - Therapeutic & Drug Delivery Platforms - Medical Technologies & Devices - Preventive Medicine & Early Diagnostics - Artificial Intelligence (AI) in Healthcare
View
Longitude Capital Longitude Capital
Longitude Capital specializes in making venture growth investments in biotechnology, medical technology and health solutions companies that seek to improve clinical outcomes, enhance quality of life, and/or reduce system costs. We invest in both privately held and publicly traded companies through a variety of investment approaches. Since 2006, Longitude Capital has raised over $1.8 billion across four funds and demonstrated an ability to source, manage, and exit attractive investments across multiple market cycles. Our venture growth strategy is rooted in building a balanced portfolio of clinical-stage and commercial-stage companies with clinically de-risked assets, favorable valuations relative to risk profile, and attractive expected returns within three to five years from initial investment. Longitude Capital seeks to identify new investment opportunities by tapping into our broad network of industry relationships or through the execution of intensive thematic research into emerging therapeutic areas or industry sub-sectors. We utilize a variety of investment structures, including traditional venture capital, asset spin-outs, recapitalizations, PIPEs, open market purchases, royalties, and other equity and equity-linked instruments. Following an initial investment, we work closely with our portfolio companies and syndicate partners to develop and implement strategic plans, achieve key operating objectives, build world-class teams, raise capital, and pursue liquidity opportunities in a manner that optimizes returns to key stakeholders. Our company name was inspired by the Longitude Prize, a competition established by the British monarchy in 1714 to solve one of the greatest scientific problems of the day. Investing in Healthcare Innovation Longitude Capital invests in biotechnology, medical technology, and health solutions companies that seek to improve clinical outcomes, enhance quality of life and/or reduce system cost. From start-ups to growth equity investments, we are dedicated to helping management teams achieve technical, clinical, and commercial milestones to create value and deliver attractive returns to our limited partners. Our Team, Your Partners Longitude Capital’s founders have been investing together since 2002. Our team has over 150 years of combined investing experience in the life sciences industry and has collaborated on over 70 new investments and 150 follow-on investments in the biotechnology, medical technology, and health solutions sectors. We operate from our offices in Menlo Park, California, Greenwich, Connecticut and Boston, Massachusetts.
View
Longship AS Longship AS
Longship is a private equity investor targeting medium sized growth companies in Norway. The Longship fund is advised by Longship AS. Longship is established by four senior partners, who all have extensive background from private equity, and with a solid and demonstrated track record of delivering value to investors. Longship is partnering with owners and high calibre management teams in successful businesses. We support our investments with financial resources and experience, in order to accelerate growth and realize their full potential.
View
LongWall Ventures LongWall Ventures
Longwall Ventures manages three venture capital funds, investing in innovative, UK based, early stage companies in the healthcare, science and engineering sectors.
View
Longwood Fund Longwood Fund
Longwood creates and invests in science-based companies that develop novel solutions for important medical problems. Longwood Fund is one of the top-performing healthcare venture capital firms that founds, manages, and builds healthcare companies. <br /> Longwood’s mission is to identify technologies and found companies that make a difference in the lives of patients, and also create significant value for investors. The Longwood team has a consistent, long history of successfully launching and building leading healthcare companies and providing operational leadership and strategic guidance.
View
Lonsdale Capital Partners LLP Lonsdale Capital Partners LLP
Lonsdale Capital Partners was set up in 2008 by Alan Dargan, Ross Finegan and David Gasparro. Alan and Ross had known each other professionally since 2000 and did their first deal together in April 2008. <br /> <br /> The idea behind the firm was to take the skills learnt over many years working in larger organisations and to apply them to the smaller end of the mid-market. <br /> <br /> The core aim is to have professionalism, experience and integrity at the heart of what we do. The team has worked on over 30 private equity deals since 1996. <br /> <br /> Towards the end of 2015, we held the first close on our first fund at over £100m, with a number of institutional LPs backing us to invest in the same way and following the same investment criteria that has been successful for us historically. The LPs also include a number of high profile and successful business people who have invested with us in the past and have provided valuable insights and contacts across their respective industries in assisting our portfolio companies. Our investment criteria is as follows: <br /> <br /> - Invest in profitable niche businesses in the UK and Europe <br /> <br /> - Target businesses are typically growing, with a proven concept <br /> <br /> - Investing in the lower end of the mid-market in companies generating between £2m and £10m of EBITDA <br /> > LPs have an appetite and capability to co-invest and hence we can consider larger transactions <br /> > We will always consider bolt-on acquisitions where appropriate <br /> <br /> - Majority only investments <br /> <br /> - Sector agnostic <br /> <br /> We are naturally conservative in the way we finance our transactions. We only employ moderate amounts of leverage (typically 2-3x EBITDA) so as not to overburden the growing companies that we support, which are also often looking at acquisitions <br /> <br /> We are not a typical mid-market PE house, and do not have boxes to tick. As a result we will look at things that might put off traditional PE, this includes: <br /> <br /> - MBIs <br /> <br /> - Majority cash outs for founders <br /> <br /> - Poor management information
View
Lorinvest Lorinvest
Lorinvest manages assets and selects pioneering companies for its portfolio, capable of providing strong returns to its shareholders and the various stockholders with whom it interacts. Our target is to generate positive impacts through all our initiatives, bringing value and prosperity to our investors, the communities and environments where our operations are developed. To achieve this, we have a differentiated team that manages high-performing assets. Lorinvest’s corporate governance stands out for its strength in conducting business and establishing solid and safe operations in all its activities. For more information, visit our website or contact us directly.
View
Lottus Capital Partners Lottus Capital Partners
Lottus Capital Partners is a private investment firm that seeks to acquire and operate in middle-market companies in Mexico. Lottus focuses on companies positioned in growth sectors, which offer strong revenues and predictable cash flow generation. Lottus aims to acquire controlling stakes via equity investments of US$5 to US25 million in privately-held companies with revenues in the range of US$5 to US$50 million.
View
Loup Ventures Loup Ventures
Loup Ventures is a research-driven, early stage venture capital firm investing in virtual reality, augmented reality, artificial intelligence and robotics.
View
Lowercase Capital Lowercase Capital
Lowercase Capital used to invest in startups and advise an array of companies and private funds. That was fun. Our approach was weird, just like our cowboy shirts. We learned a lot, helped as much as we could, and it worked out well for us. But while investing is one of our things, it is not our only thing. So, in April of 2017, we announced we would no longer be raising new venture funds. In critical times like these, we think some stuff is more important than business. What made Lowercase successful was our collaboration with founders. We rolled up our sleeves, designed product roadmaps, came up with new features, negotiated partnerships, attracted new users, recruited the core team, raised the next round of money, and honed the story. We also lent an ear and some love on those inevitably ugly days when the outlook is bleak and founders might lose hope. We invested small amounts of money and large amounts of time, attention, care, and empathy. Along the way, we played a small role in the creation of a few services that continue to shape the world, led by founders that we admire. While we aren’t raising any new funds, we still work daily with our portfolio of over 70 companies. We are grateful for the success we have enjoyed, but we understand how much could be attributed to privilege. The venture and technology industries are frustratingly devoid of diverse voices. We think we can help by doing our part to accelerate a revolution that is upending the demographics of tech investing. So for over five years, we’ve been quietly backing the next generation of investors, specifically women and people of color, who have been starting their venture funds. Now it’s time to apply what we’ve learned to causes we believe need urgent attention. Our democracy is in peril. This isn’t just the policy pendulum swinging. The United States is facing a constitutional crisis. In parallel, our global climate is in disarray and worsening every day. The world doesn’t have the political will to heal the planet, even as the lives of hundreds of millions of people hang in the balance. At the same time, our nation’s criminal justice system is a destructive, racist, and classist mess that is wrecking the lives of people of color and the poor. In these core areas, as well as others, we are donating and investing millions of dollars and countless hours. We are bringing that same obsessive passion and expertise that powered the Lowercase portfolio and applying it to a new generation of startups, funds, and organizations dedicated to improving life on Earth. The ambition of these projects is unbounded because we know no other way. We are questioning assumptions, eviscerating obstacles to success, and funding the unfundable. One of our favorite authors, Buckminster Fuller, wrote: “We are blessed with technology that would be indescribable to our forefathers. We have the wherewithal, the know-it-all, to feed everybody, clothe everybody, and give every human on Earth a chance. We know now what we could never have known before-that we now have the option for all humanity to make it successfully on this planet in this lifetime. Whether it is to be Utopia or Oblivion will be a touch-and-go relay race right up to the final moment.” We are doing everything we can to make sure Utopia wins. Thanks for doing your part too.
View